A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.

MLA

Tsai, Susan, et al. “A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.” Annals of Surgery, vol. 268, no. 4, Oct. 2018, pp. 610–19. EBSCOhost, https://doi.org/10.1097/SLA.0000000000002957.

APA

Tsai, S., Christians, K. K., George, B., Ritch, P. S., Dua, K., Khan, A., Mackinnon, A. C., Tolat, P., Ahmad, S. A., Hall, W. A., Erickson, B. A., & Evans, D. B. (2018). A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 268(4), 610–619. https://doi.org/10.1097/SLA.0000000000002957

Chicago

Tsai, Susan, Kathleen K Christians, Ben George, Paul S Ritch, Kulwinder Dua, Abdul Khan, A Craig Mackinnon, et al. 2018. “A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma.” Annals of Surgery 268 (4): 610–19. doi:10.1097/SLA.0000000000002957.